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Bone diseases and injuries are highly incapacitating and result in a high demand for tissue substitutes with
specific biomechanical and structural features. Tissue engineering has already proven to be effective in re-
generating bone tissue, but has not yet been able to become an economically viable solution due to the
complexity of the tissue, which is very difficult to be replicated, eventually requiring the utilization of highly
labor-intensive processes. Process automation is seen as the solution for mass production of cellularized bone
tissue substitutes at an affordable cost by being able to reduce human intervention as well as reducing product
variability. The combination of tools such as medical imaging, computer-aided fabrication, and bioreactor
technologies, which are currently used in tissue engineering, shows the potential to generate automated pro-
duction ecosystems, which will, in turn, enable the generation of commercially available products with
widespread clinical application.
Introduction
Bone is a dense and specialized form of connective tis-sue responsible for supporting and protecting the body
and its organs. Its complex architecture is built from type I
collagen and calcium phosphate in the form of hydroxyapatite
resulting in unique biomechanical properties, which are dif-
ficult to mimic artificially. Bone diseases and injuries are
therefore highly incapacitating and are increasingly becoming
a major socioeconomic issue.1 About 2 million bone grafting
procedures take place annually worldwide to ensure adequate
bone healing in many skeletal problems generating a turnover
of about 1 billion US dollars a year.2 Autotransplantation
employing bone harvested from patients’ donor sites is the
most common procedure due to its inherent histocompati-
bility and nonimmunogenicity.3 However, the sourcing of
grafts in the patient’s body enhances tissue morbidity, blood
loss, risk of infection and fracture, operative time and cost,
and results in long immobilization periods and postoperative
pain. To eliminate these drawbacks, synthetic products such
as Ostim (Aap Implantable AG), Kasios and Jectos
(Kasios), and Pro Osteon (Biomet, Inc.) composed of hy-
droxyapatite and/or calcium phosphates and natural products
of xenogeneic origin such as Bio-Oss (Geistlich Pharma)
have been introduced in the market. However, these products
have high production cost and are mainly provided in the
form of granules or pastes showing reduced ability to repair
complex and/or high load demanding defects.
Over the last two decades, tissue engineering has shown
great promise in regenerating human tissues by employing
exogenously generated substitutes. Since then, various types
of tissue substitutes, such as bone,4 cartilage,5 or skin,6 have
been successfully generated in vitro. Despite initial projec-
tions (80 billion USD market by 2012) and extensive cor-
porate investment, the translation of these ground-breaking
technologies from the laboratory to a widespread clinical
application revealed to be modest.7 The most commercially
successful tissue-engineered product so far was Apligraf, a
skin substitute produced by Organogenesis, Inc. which, de-
spite its proven effectiveness and relative simplicity,
reached a very small part of its potential market given its
labor-intensive and costly production process.7 Since bone
tissue is more complex and difficult to regenerate than skin,
mainly due to its structural and biomechanical properties,
the task of creating commercially viable tissue-engineered
bone replacement products is even more arduous. Automa-
tion is probably one of the key issues for enabling the
generation of bone substitutes with enhanced complexity in
a time- and cost-effective manner, allowing an effective
shift from labor-intensive production to mass production.
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In this article, we review several production steps of the
process for the generation of bone substitutes focusing on
the available options that rely on automated tools and
strategies, which are currently applied in tissue engineering,
namely, three-dimensional (3D) medical imaging, computer-
aided design (CAD), additive manufacturing, and bioreactor
technologies (Fig. 1). Unlike the currently existing literature
that address these technologies separately,8,9 this review
article considers that they can all be combined together into
a highly integrated and automated ecosystem.
Imaging Tools for Design
Technological advancement has enabled the visualization
of human tissues and organs to levels of detail as never seen
before and, by doing so, it has become possible to under-
stand the structure–function relationship at the level of cells,
tissues, and organs. With the advent of tissue engineering
and regenerative medicine, it becomes now possible to not
only observe but to mimic those same structures in such a
way that the replacement and regeneration of damaged tis-
sues and organs are possible.
Currently existing technologies for noninvasive imaging
allow for body parts or whole bodies to be analyzed without
any damage to the target tissues. Technologies, such as
magnetic resonance imaging (MRI) and, in particular, com-
puterized tomography (CT), enable the collection of data from
bone tissue sites that need to be repaired (Table 1). Given the
high degree of resolution provided by such technologies, it
becomes possible to obtain not only information related to the
outer shape of the defect and organ but also information re-
lated to their more complex inner porosity, density, and mi-
crostructure. This data can even be used for indirectly
assessing other tissue parameters, such as mechanical prop-
erties, by comparison with calibration phantoms.10
Softwares such as Mimics (Materialise NV), the CTAn+
CTVol package (SkyScan NV),11 or Invesalius (Renato Ar-
cher Technology of Information Center, Brazil)12 are spe-
cialized in converting raw CT/MRI data (in the form of
sequential two-dimensional (2D) images made of density-
based grayscale-colored pixels) into 3D models by combining
these 2D images into 3D stacks. According to a desired
density threshold, density-based shapes and volumes can
therefore be defined in 3D and selected out of the 3D stack.
Finally, the obtained shapes are used to generate a volume, a
3D model, consisting of the volume contained in its interior
(Fig. 1A). The analysis of parameters such as densities, vol-
umes, and porosities may differ according to the software-
specific algorithms, the scanning equipment, and contrasting
agents used. Bone tissue also exhibits very irregular outer
shapes, which are difficult to mimic by other means than CT
or MRI. In a work by Grayson et al.13 medical CT was used
to scan a bovine temporomandibular joint condylar bone and
then fabricate an anatomically shaped scaffold replica by
computerized numerically controlled milling of a bone ex-
plant block. This solution was very successful in generating a
tailor-made functional bone substitute despite the above-
mentioned drawbacks associated with bone explants.
Design by Replication of Real Tissue Models
Apart from replication, current technological develop-
ment allows to improve on the natural design of tissues and
organs and maximize the functionality of de novo generated
substitutes as well as facilitating their manufacture.
The replication of tissue parts by reconstruction of CT or
MRI scans usually involves a certain extent of design
modifications, which are applied to CT- or MRI-generated
3D models (such as reorientation, edge smoothing, and
mesh simplification operations), to facilitate and accelerate
the 3D model manipulation, fabrication, and integration
within the target site. The reconstructed 3D model can also
be manually redesigned or combined with other 3D models
(CT/MRI originated or CAD designed) to improve their
functionality. Otherwise, in cases where there is a complete
or substantial lack of tissue to be scanned and reconstructed,
it becomes necessary to resort to other reference tissues
possessing similar shapes and properties in order for their
3D models to be adapted to the target site by reverse engi-
neering.14
The most simple way of using a CT/MRI-generated 3D
model for generating tissue substitutes is by simply con-
verting the reconstructed 3D model (which is initially solid)
into a model containing repeating porosity patterns (which
will later originate a porous implant). Porosity and pore
interconnectivity are crucial parameters in the efficiency of
tissue-engineered implantable devices since they allow
preseeded cells to proliferate and populate the inner parts of
the device while receiving sufficient nutrition as well as
neovascularization and tissue ingrowth coming from the
native tissues surrounding the device upon implantation.15–17
Porosity, together with pore interconnectivity and archi-
tecture, can also be greatly responsible for other features
such as the mechanical properties of the device. The me-
chanical properties of scaffolds can also be adjusted ac-
cording to numerically generated models to meet the desired
requirements.18
Porosity patterns can be generated by using design-based
methods19 and/or fabrication-based methods20 either by
simple repetition of predetermined subunits21 or generated
by means of mathematical models developed by analysis of
the target tissue structure22,23 (Fig. 2). Design-based meth-
ods imply further manipulation and modification of the 3D
model and rely on the generation of a regular 3D matrix,
which overlaps the 3D model. This 3D matrix is populated
by subunits possessing predetermined geometries, which are
used for locally performing either intersection or subtraction
Boolean operations over the 3D model (Fig. 2A). A Boolean
object resulting from an intersection operation will contain
only the volume that was common to both original objects
(3D model and subunits), while a Boolean object resulting
from a subtraction operation will consist of the volume of
the original object (3D model) with the intersection volume
(subunits) subtracted from it. The main restriction in the
design of these subunits is that they must be able to adja-
cently intersect with each other at some point. In the case of
intersection Boolean operations, this feature becomes cru-
cial since, upon fabrication, this allows for the device to
maintain its structural and mechanical integrity. When
performing subtraction Boolean operations, this feature is
mostly important in keeping the interconnectivity of pores.
Fabrication-based methods on the other hand imply the
manipulation of operating parameters utilized in the process
of fabrication itself. When ready for fabrication, the 3D
model is horizontally sliced and each slice filled with
568 COSTA ET AL.
FIG. 1. Schematic representation of process for mass production of personalized bone substitutes. The process starts with
a three-dimensional (3D) reconstruction obtained by medical imaging (A), which allows to produce scaffolds replicating the
shape and structure of the target tissues (B) as well as shape-specific culture chambers (C) into which scaffolds are
optimally seeded and cultured with cells in large scale (D). Color images available online at www.liebertpub.com/teb
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patterned lines is then used by the fabrication machine-
controlling software as guiding pathways for activating and
moving the machine’s tools. Pattern types can vary from just
simple sets of parallel lines to more complex mathemati-
cally calculated patterns (Fig. 2B). Slice thickness and line
spacing are other common examples of simple parameters
that can be easily manipulated to substantially change the
amount, size, and interconnectivity of pores. As in design-
based methods, the only vital requirement in the generation
of these patterns is that, upon fabrication, all the patterned
layers are attached to each other at some point and forming a
single object capable of maintaining its structural and me-
chanical integrity. Both design-based and fabrication-based
methods provide an enormous array of possibilities when
developing tissue engineering devices. Furthermore, the
combination of design-based and fabrication-based methods
is also an option and can generate an even more immense
array of design possibilities. The combination of both can be
used for generating distinct, but integrated types of porosity
into one single device (Fig. 2C).
Fabrication with Accuracy and Reproducibility
To be able to fabricate structures as complex as tissues
and organs, high-precision tools need to be employed. These
tools must allow to accurately position cell and material
building blocks, but also enable the 3D positioning neces-
sary to generate fully functional 3D constructs.
Additive manufacturing is a highly automated layer-
by-layer process that, unlike subtractive rapid prototyping,
involves the sequential building of layers of material by
deposition of new layers on top of previously laid layers of
material. The first main application of additive manufacturing
in the medical field was in helping to plan surgeries. By
building real-size models accurately mimicking tissue fea-
tures contained in the interior of the body, it was possible for
surgeons to better plan surgical procedures.24 Furthermore,
surgical guides for tool orientation were also built by additive
manufacturing enabling as well a better execution of the
surgical procedure itself.25,26
In general, an additive rapid prototyping material must be
convertible to a more versatile form, such as a liquid, a
colloidal, or a powder form, (typically by applying high
temperatures or solvents), to be selectively and accurately
added to layers. After deposition, the chosen material must
be able as well to directly or indirectly attach back together
in order for adjacent layers to be efficiently joined together
during the layer-by-layer process.
Despite the existence of a wide array of materials able to
be used in the additive manufacturing of bone scaffolds,
polycaprolactone (PCL) and poly(lactic acid) (PLA) are the
most commonly used materials (either alone or combined
with other materials) due to their biodegradability and ad-
equate mechanical properties as well as their approval for
medical implantation. Another material of great interest for
fabricating bone scaffolds is hydroxyapatite, which is a
natural constituent of bone. Hydroxyapatite can be utilized
in additive manufacturing by applying significantly higher
processing temperatures than PCL or PLA when directly
deposited. Alternatively, hydroxyapatite scaffolds can as
well be indirectly fabricated by casting into sacrificial molds
fabricated by additive manufacturing.27
The array of specialized materials that can be utilized in
additive rapid prototyping, although not as wide as in sub-
tractive rapid prototyping, is still quite large and is con-
stantly evolving given that there is currently a wide range of
additive rapid prototyping technologies and that each one
utilizes materials with specific properties for adequate
FIG. 2. Schematic repre-
sentation of generation of
porosity into a 3D model by
means of design- and fabri-
cation-based methods. (A)
Boolean operations em-
ployed in design-based po-
rosity generation. (B)
Examples of patterns of var-
ied complexity employed in
fabrication-based porosity
generation. (C) Scaffold
possessing design- and fab-
rication-based porosity. B4
modified with permission
from Chen et al.22 Color
images available online at
www.liebertpub.com/teb
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processing (Table 1). Fused deposition modeling (FDM)
and selective laser sintering (SLS) are the most commonly
used additive manufacturing technologies in bone tissue
engineering applications, mostly due to the possibility of
manufacturing objects, which possess mechanical properties
similar to the ones found in native bone, while at the same
time maintaining a high degree of control over the outer and
inner architecture of the manufactured object. SLS results
from the fusion of particles contained in a powder layer by
means of directed laser radiation.28,29 A thin layer of powder
is first spread over a flat surface and then irradiated by a
laser beam, which is oriented to selected locations of the
powder layer. As a result, the irradiated powder particles are
fused together forming 2D patterns. The laser beam is then
stopped and a new layer of powder is spread over the pre-
cedent layer by means of a mechanical roller. The patterned
fusion process is then repeated resulting in the fusion of the
new patterned layer with the layer beneath. At the end of
the process, the excess powder is removed uncovering the
manufactured object (Fig. 3A). On the other hand, FDM
consists of the extrusion of molten material from a heated
extruder forming a thin filament that is laid down over a
deposition surface moving over three axes relative to the
extrusion nozzle.30 By coordinating the movement of the
deposition table and the extrusion in the nozzle, highly de-
tailed patterns of thermoplastic material can be created over
the deposition surface. When the deposition of one layer of
material is finished, the extrusion is stopped while the de-
position table is slightly moved away from the extruder tip.
The extrusion is then restarted and a new patterned layer is
deposited over the precedent layer to which it adheres (Fig.
3B). FDM and SLS technologies may, however, need to be
complemented with other additive manufacturing technol-
ogies, such as bioprinting, to replicate specific features
contained into the bone tissue structure. Bioprinting results
from the extrusion of material from a nozzle, but unlike
FDM it does not involve heating. Therefore, the extrusion
process can involve sensitive materials such as gels and
cellular aggregates.31 Typically, the process is started with
the patterned deposition of a gel filament, which forms a
grooved layer. This gel layer then allows for further depo-
sition of a second material, which is composed of small
cellular aggregates. The deposition of those aggregates into
the grooves formed by the gel layer ensures that the cellular
aggregates are kept in their exact positions. This process is
repeated layer over layer generating 3D shapes composed of
cellular aggregates that, during further maturation, fuse to-
gether and generate continuous masses of cells possessing a
predetermined shape (Fig. 3C). A particular application of
bioprinting is in the formation of blood vessel networks
contained in bone. Blood vessel networks are flexible and
delicate structures possessing mechanical properties very
different from the surrounding tissue. These structures have
so far been mimicked by applying gel-based or even scaf-
fold-free printing technologies, which are able to lay down
intricate patterns of cells that later generate vessel-like
structures. An example of that is shown in a work by Nor-
otte et al.,32 where bioprinting was utilized to concomitantly
lay down aggregates of various cell types according to
predefined patterns, which during further maturation fused
together and generated stratified 3D vessel-like structures.
Furthermore, previous works show as well that soft mate-
rials such as gels can be further integrated into the structure
of more stiff thermoplastic scaffolds resulting in scaffolds
possessing optimal mechanical properties.33,34 By using a
similar strategy and applying design principles mimicking
the natural organization of blood vessels,35–37 the concom-
itant integration of bioprinted blood vessels into the struc-
ture of more mechanically stable scaffolds produced by
technologies such as FDM or SLS would potentially enable
the generation of mechanically stable vascularized bone
tissue substitutes (Fig. 1B).
Culturing Cells in 3D Templates
Despite being highly labor intensive and expensive, static
culture is still the most widely used cell culture technique in
tissue engineering strategies. This culturing technique is
often characterized by nonhomogenous cell distribution,
being the majority of seeded cells confined to the outer
surfaces of the scaffold, which in turn results in non-
homogenous distribution of the in vitro-generated extracel-
lular matrix. Furthermore, static culturing conditions are far
from mimicking the dynamic environment found in vivo,
which is responsible for many signals/stimuli that trigger
cell development. Dynamic cell culture has been shown to
avoid cell death in the construct’s core by improving the
mobility of nutrients into these most central regions as well
as influencing cellular development.38–41 Hence, many dy-
namic culture devices possessing varying degrees of auto-
mation have so far been developed to overcome the
limitations found in static culture. These systems are able to
culture tissue-engineered constructs into highly controlled
environments while providing a wide array of biomechani-
cal stimuli (Fig. 4). Stimulatory signals applied in bone
tissue engineering such as perfusion-based shear stress,42,43
direct mechanical compression,44 and hydrostatic compres-
sion45 have shown to be effective in improving the qual-
ity of generated constructs (Table 1). In fact, such results
would be expected since such stimuli can be found influ-
encing bone development in a similar way when applied
in vivo.46,47 Bioreactors are able to modulate cellular de-
velopment through a mechanism of mechanotransduction,
which consists of triggering intracellular biochemical sig-
nals by means of mechanical deformation of the cellular
structure.48 Perfusion bioreactors employ pumps to contin-
uously perfuse the culture medium through the inter-
connected porous networks of cell-seeded scaffolds. Shear
stress resulting from the movement of fluid over the surface
of cells in the scaffolds results in the deformation of the
structure of cells and triggers mechanotransductive down-
stream signaling (Fig. 4A). Given their simplicity, flow
perfusion bioreactors enable seeding and culture of cells into
scaffolds with a high degree of automation. In a different
way, bioreactors performing direct mechanical compression
are inspired by the mechanical compressive forces felt by
tissues in their natural environment during movement. Cells
contained in porous scaffolds are stimulated by the defor-
mation that occurs in the structure of the scaffold during
compression/relaxation (Fig. 4B). Shear stress can as well
occur as a result from the movement of fluids from/to the
interior of the scaffold’s pores during deformation. Finally,
in hydrostatic pressure bioreactors, mechanical forces act
directly over the membranes of cells contained in porous
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scaffolds by means of a fluid. When the pressure of the fluid
(culture medium) contained in the bioreactor (and in the
scaffold’s pores) is increased/decreased, it acts upon the
cellular membrane by causing a compression/relaxation
deformation (Fig. 4C). Apart from being able to simplify
and automate the process of construct culture, bioreactors in
general show as well the potential to generate constructs in a
more standardized, traceable, cost-effective, safe, and reg-
ulatory-compliant way.9,49
Bioreactors must also be versatile, being able to adapt to
various kinds of constructs possessing variable degrees of
complexity and aimed at diverse applications. This is why
bioreactors, as well as their fabrication process, must be
easily adjustable to specific conditions and requirements on
the fly. Recent work addressed this requirement by resorting
to additive manufacturing not only to fabricate scaffolds but
as well to simultaneously fabricate their enclosing culture
chamber.50 In this way, complex-shaped constructs could be
produced to replicate the shape of CT-scanned bone parts
while contained in a culture chamber optimally designed for
that specific construct (Fig. 1C).
Another aspect, which is important for the application of
tissue engineering into the clinic, is process scalability. In a
scenario of widespread adoption of tissue engineering-based
therapies, significant amounts of sufficiently large constructs
would need to be simultaneously produced to fulfill clinical
demands (Fig. 1D). Many scalable and modular systems
have been developed to address this requirement by resort-
ing to various fabrication processes to enable the simulta-
neous culture of multiple and/or large constructs.40,51–53
A specific application, where this is already visible (al-
though usually at a smaller construct scale), is in the high-
throughput screening of biomaterials where cells contained
in multiple simplified 3D constructs are submitted to vary-
ing culture environments to fully understand and optimize
their development.54,55
As the human body, bioreactors must as well be able to
continuously sense and accordingly react to all the events
occurring in the construct and its surrounding environment
during culture. Many kinds of sensors and analytical tech-
niques have been so far integrated into bioreactor-based
procedures. The most common ones are based on electro-
chemical and optical principles and are usually applied in an
invasive, noninvasive, or shunt configuration.56 Some of them
are commonly used in other types of fully scaled-up cultures
such as the culture of yeasts or bacterial microorganisms for
mass production of food and drug compounds as well as in
clinical and physiological monitoring.57 A very interesting
type of bioreactor, with particular utility for bone tissue en-
gineering, is able to perform noninvasive high-resolution
analysis of bone constructs under perfusion culture by means
of micro-CT scanning.58,59 In this way, tissue constructs do
not need to be removed from its culture chamber every time a
scan is performed, hence reducing human labor as well as
minimizing the possibility of contamination.
Personalized Bone Tissue Engineering Resulting
from Integrated Manufacturing Ecosystems
The provision of personalized treatments for patient-
specific requirements is seen as the next big step in healthcare
toward cost-effective, efficient and improved patient outcomes.
FIG. 3. Schematic representation of the mode of operation
of selective laser sintering (A), fused deposition modeling
(B), and bioprinting (C). Color images available online at
www.liebertpub.com/teb
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The ability to automate the design, fabrication, and culture
steps in tissue engineering (Fig. 1) not only enables to reduce
human intervention but as well to generate more complex and
personalized constructs. The generation of personalized bone
tissue substitutes has, in fact, been explored in the field of
tissue engineering for over a decade in various ways. Back in
the year 2000, Hollister et al. had already described a medical
image-based computational method for generating 3D scaf-
folds closely mimicking the outer and inner architectures of
bone parts.19 Despite the high potential of this method, the
generated personalized bone-like structures were produced
from epoxy resin by means of stereolithography and not from
implantable materials, validating mostly the design method but
not demonstrating its full in vitro or in vivo application. In a
way, this work demonstrated that, by utilizing advanced
technologies to make more complex scaffolds, it becomes also
more challenging to seed and culture cells and tissues into
them. In 2010, Grayson et al. addressed this issue by realizing
that, together with customized implants, it was also necessary
to produce customized cell and tissue culture environments
(implant-specific bioreactor chambers) to successfully promote
the formation of healthy and fully functional tissue substitutes
into complex personalized scaffolds.13 However, the main
disadvantage of such strategy was that, since it employed
several different materials and technologies of varying degrees
of automation to build both the implant and corresponding
chamber, the manufacturing of such devices became overly
scattered, complex, and laborious.
An efficient way of improving the productivity of a
manufacturing system is by reducing the number of pro-
duction steps to a minimum while also employing a reduced
number of highly versatile tools. This simplifies the process
of manufacturing highly customized products and facilitates
the integration of all production tools into a smart and lean
manufacturing ecosystem. A recent concept for generating
personalized tissue-engineered constructs has followed such
strategy by electing additive manufacturing as its main
multipurpose tool.50 In a recent work employing this con-
cept, additive manufacturing combined with medical im-
aging was utilized to simultaneously generate, in one single
step, personalized scaffolds readily contained into person-
alized and readily automatable culture environments, into
which cells and tissues could be cultured to generate bone-
like constructs.60 This achievement was only possible since
additive manufacturing, medical imaging, and bioreactor
technologies are heavily based on software. The ability to
manipulate digital information instead of physical objects
enables an enormous degree of creative freedom that is
simply not possible in the physical world. Furthermore,
digital information is much easier to manage, combine, and
FIG. 4. Scheme showing how perfusion, mechanical compression, and hydrostatic compression bioreactors are able to
mechanically deform cells to stimulate their development. Red arrows indicate fluid movement and blue arrows indicate
mechanical forces. (A) Perfusion bioreactor, (B) Direct mechanical compression bioreactor, and (C) Hydrostatic com-
pression bioreactor. Color images available online at www.liebertpub.com/teb
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modify, and therefore becomes the most suitable way of
integrating the most diverse tools and technologies into
common strategies.
Concluding Remarks and Future Directions
The automation of tissue engineering is becoming a re-
ality. Important advancements in this area allowed so far to
mostly create and identify the basic enabling technologies
necessary for the proper development of this field. None-
theless, and given the high complexity of bone tissue, it
becomes necessary to develop equally complex develop-
ment strategies, but these must result in simpler methodol-
ogies and technologies that enable automation and thus,
easier processing into industrial viable products that can
reach large-scale clinical application. The rapid develop-
ment in computer and automation technologies as well as
the achievement of higher resolution powers in analysis and
fabrication processes increasingly enables tissue engineers
to more closely mimic the complex and highly dynamic
environments found in native tissues. The convergence of
these technologies allied to an increasingly better under-
standing of the mechanisms at the basis of tissue develop-
ment will in the future allow for the generation of tissue
replicas possessing similar or even improved features.
Equally important is the training of highly skilled hybrid
scientists capable of mastering and combining all the in-
volved technologies into generating mass produced, tailor-
made, patient-specific solutions.
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